The annual Conference on Retroviruses and Opportunistic Infections (CROI) was held in Seattle, USA from 4 to 7 March 2019.

Conference highlights

The search for a cure

London patient in long-term HIV remission after stem cell transplant.

Achieving the 90-90-90 target

HIV infections lowered by 30% in universal testing and treatment study.


Long-acting HIV treatment

Long-acting injectable treatment maintains viral suppression.

Epidemiology

55% drop in HIV incidence in gay men in England in just two years.

Hepatitis C

Hepatitis C drops among HIV-positive London gay men after direct-acting antiviral scale-up.


Child development issues

Neural tube defects and integrase inhibitors: still waiting for stronger evidence.

Resistance

One in six South Africans drug resistant before starting HIV treatment.

Health monitoring

Are CD4 counts still useful in the 'treat all' era?


aidsmap news

There is no aidsmap news from CROI 2019 yet. Showing all aidsmap news instead.

Editors' picks from other sources

There are no Editors' Picks from CROI 2019 yet. Showing all Editors' picks instead.

News bulletins

Sign up for our email bulletins

Find out more and sign up to the full range of aidsmap email bulletins >

Official conference website

Find out more on the official conference website.

Visit the conference website >
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.